No Data
Cathie Wood's Ark Invest Loads Up On Intellia Therapeutics Which Laid Off Over A Quarter Of Its Workforce
Does Recursion Pharmaceuticals (RXRX) Have the Potential to Rally 27.96% as Wall Street Analysts Expect?
Trending Industry Today: SoundHound AI Leads Losses In NVIDIA Portfolio Stocks
Cathie Wood's ARK Investment Buys 653K Shares of Recursion Pharmaceuticals Today
Recursion Pharmaceuticals Is Maintained at Overweight by Keybanc
Recursion Pharmaceuticals Analyst Ratings